ARATANA THERAPEUTICS, INC. Common Stock PLACEMENT AGENCY AGREEMENT May 3, 2017Placement Agency Agreement • May 4th, 2017 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Aratana Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to certain investors (each, an “Investor” and collectively, the “Investors”) up to an aggregate of 5,000,000 shares (the “Shares”) of the common stock, par value $0.001 per share, of the Company (“Common Stock”). Barclays Capital Inc. (“Barclays”) has agreed to act as placement agent (the “Placement Agent”) in connection with such issuance and sale of the Shares.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 4th, 2017 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 3, 2017, by and among Aratana Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule A attached hereto (each, a “Purchaser,” and collectively, the “Purchasers”).
